about
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also con...
Read More
1.46
0.01
(0.69%)
3.6M
XNAS Volume
XNAS 29 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Polyrizon Ltd. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..